The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 1,050,277 | 39,292,086 | SH | SOLE | 39,292,086 | 0 | 0 | ||
Abeona Therapeutics Inc. | COM | 00289Y107 | 6,158 | 1,288,235 | SH | SOLE | 1,288,235 | 0 | 0 | ||
Acceleron Pharma Inc. | COM | 00434H108 | 3,447 | 83,900 | SH | SOLE | 83,900 | 0 | 0 | ||
Achillion Pharmaceuticals, Inc. | COM | 00448Q201 | 2,936 | 1,095,359 | SH | SOLE | 1,095,359 | 0 | 0 | ||
Acorda Therapeutics, Inc. | COM | 00484M106 | 15,426 | 2,011,189 | SH | SOLE | 2,011,189 | 0 | 0 | ||
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 1,070 | 172,630 | SH | SOLE | 172,630 | 0 | 0 | ||
Adaptive Biotechnologies Corporation | COM | 00650F109 | 56,289 | 1,165,411 | SH | SOLE | 1,165,411 | 0 | 0 | ||
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 11,738 | 1,713,604 | SH | SOLE | 1,713,604 | 0 | 0 | ||
Affimed N.V. | COM | N01045108 | 574 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Aileron Therapeutics, Inc. | COM | 00887A105 | 1,469 | 2,040,000 | SH | SOLE | 2,040,000 | 0 | 0 | ||
Aimmune Therapeutics, Inc. | COM | 00900T107 | 14,031 | 673,908 | SH | SOLE | 673,908 | 0 | 0 | ||
Albireo Pharma, Inc. | COM | 01345P106 | 8,060 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 1,081,642 | 8,258,068 | SH | SOLE | 8,258,068 | 0 | 0 | ||
Alkermes plc | SHS | G01767105 | 9,016 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Amarin Corporation plc | SPONSORED ADR | 023111206 | 805,544 | 41,544,288 | SH | SOLE | 41,544,288 | 0 | 0 | ||
AnaptysBio, Inc. | COM | 032724106 | 6,380 | 113,086 | SH | SOLE | 113,086 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | COM | 03753U106 | 7,950 | 313,725 | SH | SOLE | 313,725 | 0 | 0 | ||
Aquestive Therapeutics, Inc. | COM | 03843E104 | 418 | 99,600 | SH | SOLE | 99,600 | 0 | 0 | ||
Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | 25,805 | 10,934,154 | SH | SOLE | 10,934,154 | 0 | 0 | ||
Aravive, Inc. | COM | 03890D108 | 2,910 | 484,947 | SH | SOLE | 484,947 | 0 | 0 | ||
Arcus Biosciences, Inc. | COM | 03969F109 | 966 | 121,534 | SH | SOLE | 121,534 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 144,349 | 1,019,557 | SH | SOLE | 1,019,557 | 0 | 0 | ||
Array BioPharma Inc. | COM | 04269X105 | 131,974 | 2,848,567 | SH | SOLE | 2,848,567 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 390,390 | 3,390,270 | SH | SOLE | 3,390,270 | 0 | 0 | ||
Assembly Biosciences, Inc. | COM | 045396108 | 10,836 | 803,246 | SH | SOLE | 803,246 | 0 | 0 | ||
Atreca, Inc. | CL A Common | 04965G109 | 66,557 | 3,532,760 | SH | SOLE | 3,532,760 | 0 | 0 | ||
Audentes Therapeutics, Inc. | COM | 05070R104 | 57,034 | 1,506,438 | SH | SOLE | 1,506,438 | 0 | 0 | ||
Autolus Therapeutics plc | SPONSORED ADS | 05280R100 | 2,524 | 156,773 | SH | SOLE | 156,773 | 0 | 0 | ||
Axsome Therapeutics, Inc. | COM | 05464T104 | 19,886 | 772,286 | SH | SOLE | 772,286 | 0 | 0 | ||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 1,459,794 | 11,777,285 | SH | SOLE | 11,777,285 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | COM | 079481107 | 4,552 | 2,677,818 | SH | SOLE | 2,677,818 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 54,510 | 14,382,673 | SH | SOLE | 14,382,673 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 650,023 | 7,589,294 | SH | SOLE | 7,589,294 | 0 | 0 | ||
bluebird bio, Inc. | COM | 09609G100 | 5,088 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 9,828 | 2,559,461 | SH | SOLE | 2,559,461 | 0 | 0 | ||
Cerus Corporation | COM | 157085101 | 60,415 | 10,749,937 | SH | SOLE | 10,749,937 | 0 | 0 | ||
ChemoCentryx, Inc. | COM | 16383L106 | 1,925 | 207,029 | SH | SOLE | 207,029 | 0 | 0 | ||
Constellation Pharmaceuticals, Inc. | COM | 210373106 | 1,637 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | ||
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 3,325 | 132,985 | SH | SOLE | 132,985 | 0 | 0 | ||
Cyclerion Therapeutics, Inc. | COM | 23255M105 | 2,320 | 202,581 | SH | SOLE | 202,581 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 40,865 | 5,707,411 | SH | SOLE | 5,707,411 | 0 | 0 | ||
CytomX Therapeutics, Inc. | COM | 23284F105 | 2,181 | 194,377 | SH | SOLE | 194,377 | 0 | 0 | ||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 45,289 | 5,509,560 | SH | SOLE | 5,509,560 | 0 | 0 | ||
Dermira, Inc. | COM | 24983L104 | 8,670 | 906,943 | SH | SOLE | 906,943 | 0 | 0 | ||
Dova Pharmaceuticals, Inc. | COM | 25985T102 | 1,402 | 99,405 | SH | SOLE | 99,405 | 0 | 0 | ||
Dynavax Technologies Corporation | COM | 268158201 | 299 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd. | SHS | M46135105 | 1,186 | 498,189 | SH | SOLE | 498,189 | 0 | 0 | ||
Forty Seven, Inc. | COM | 34983P104 | 2,650 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Fulgent Genetics, Inc. | COM | 359664109 | 835 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
G1 Therapeutics, Inc. | COM | 3621LQ109 | 3,901 | 127,236 | SH | SOLE | 127,236 | 0 | 0 | ||
GW Pharmaceuticals plc | ADS | 36197T103 | 63,930 | 370,845 | SH | SOLE | 370,845 | 0 | 0 | ||
Galapagos NV | SPONSORED ADR | 36315X101 | 3,233 | 25,072 | SH | SOLE | 25,072 | 0 | 0 | ||
Galmed Pharmaceuticals Ltd. | SHS | M47238106 | 1,585 | 215,594 | SH | SOLE | 215,594 | 0 | 0 | ||
Genomic Health, Inc. | COM | 37244C101 | 538,708 | 9,260,922 | SH | SOLE | 9,260,922 | 0 | 0 | ||
HOOKIPA Pharma Inc. | COM | 43906K100 | 6,009 | 892,857 | SH | SOLE | 892,857 | 0 | 0 | ||
Halozyme Therapeutics, Inc. | COM | 40637H109 | 5,153 | 299,969 | SH | SOLE | 299,969 | 0 | 0 | ||
Harpoon Therapeutics, Inc. | COM | 41358P106 | 2,786 | 214,285 | SH | SOLE | 214,285 | 0 | 0 | ||
Heron Therapeutics, Inc. | COM | 427746102 | 111,877 | 6,018,104 | SH | SOLE | 6,018,104 | 0 | 0 | ||
IDEAYA Biosciences, Inc. | COM | 45166A102 | 1,992 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Idera Pharmaceuticals, Inc. | COM PAR | 45168K405 | 12,298 | 4,605,822 | SH | SOLE | 4,605,822 | 0 | 0 | ||
Incyte Corporation | COM | 45337C102 | 2,716,697 | 31,976,193 | SH | SOLE | 31,976,193 | 0 | 0 | ||
Infinity Pharmaceuticals, Inc. | COM | 45665G303 | 1,045 | 580,400 | SH | SOLE | 580,400 | 0 | 0 | ||
Insmed Incorporated | COM PAR $.01 | 457669307 | 63,033 | 2,462,216 | SH | SOLE | 2,462,216 | 0 | 0 | ||
Intellia Therapeutics, Inc. | COM | 45826J105 | 2,104 | 128,538 | SH | SOLE | 128,538 | 0 | 0 | ||
Invitae Corporation | COM | 46185L103 | 91,707 | 3,902,421 | SH | SOLE | 3,902,421 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 37,906 | 2,799,577 | SH | SOLE | 2,799,577 | 0 | 0 | ||
Kodiak Sciences, Inc. | COM | 50015M109 | 106,998 | 9,145,115 | SH | SOLE | 9,145,115 | 0 | 0 | ||
Krystal Biotech, Inc. | COM | 501147102 | 41,666 | 1,034,674 | SH | SOLE | 1,034,674 | 0 | 0 | ||
La Jolla Pharmaceutical Company | COM PAR $.0001 2 | 503459604 | 14,423 | 1,559,231 | SH | SOLE | 1,559,231 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 122,552 | 1,169,278 | SH | SOLE | 1,169,278 | 0 | 0 | ||
Marker Therapeutics, Inc. | COM | 57055L107 | 11,880 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
Menlo Therapeutics Inc. | COM | 586858102 | 4,193 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
Merus N.V. | COM | N5749R100 | 16,994 | 1,160,014 | SH | SOLE | 1,160,014 | 0 | 0 | ||
Milestone Pharmaceuticals Inc. | COM | 59935V107 | 7,240 | 266,667 | SH | SOLE | 266,667 | 0 | 0 | ||
Mirati Therapeutics, Inc. | COM | 60468T105 | 258,887 | 2,513,462 | SH | SOLE | 2,513,462 | 0 | 0 | ||
Molecular Templates, Inc. | COM | 608550109 | 2,123 | 254,230 | SH | SOLE | 254,230 | 0 | 0 | ||
MyoKardia, Inc. | COM | 62857M105 | 50,958 | 1,016,306 | SH | SOLE | 1,016,306 | 0 | 0 | ||
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 3,660 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | COM | 64125C109 | 119,492 | 1,415,283 | SH | SOLE | 1,415,283 | 0 | 0 | ||
NextCure, Inc. | COM | 65343E108 | 2,247 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
Orchard Therapeutics plc | ADS | 68570P101 | 5,676 | 405,702 | SH | SOLE | 405,702 | 0 | 0 | ||
Principia Biopharma Inc. | COM | 74257L108 | 59,337 | 1,787,807 | SH | SOLE | 1,787,807 | 0 | 0 | ||
Protagonist Therapeutics, Inc. | COM | 74366E102 | 12,050 | 995,082 | SH | SOLE | 995,082 | 0 | 0 | ||
Ra Pharmaceuticals, Inc. | COM | 74933V108 | 54,177 | 1,801,695 | SH | SOLE | 1,801,695 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 59,580 | 2,708,200 | SH | SOLE | 2,708,200 | 0 | 0 | ||
Ritter Pharmaceuticals, Inc. | COM | 767836307 | 300 | 279,999 | SH | SOLE | 279,999 | 0 | 0 | ||
Sangamo Therapeutics, Inc. | COM | 800677106 | 10,768 | 999,823 | SH | SOLE | 999,823 | 0 | 0 | ||
Seattle Genetics, Inc. | COM | 812578102 | 3,464,464 | 50,057,277 | SH | SOLE | 50,057,277 | 0 | 0 | ||
Sierra Oncology, Inc. | COM | 82640U107 | 1,120 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
Spark Therapeutics, Inc. | COM | 84652J103 | 76,982 | 751,927 | SH | SOLE | 751,927 | 0 | 0 | ||
Spring Bank Pharmaceuticals, Inc. | COM | 849431101 | 2,263 | 613,144 | SH | SOLE | 613,144 | 0 | 0 | ||
Sunesis Pharmaceuticals, Inc. | COM PAR | 867328700 | 405 | 556,665 | SH | SOLE | 556,665 | 0 | 0 | ||
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 9,027 | 974,835 | SH | SOLE | 974,835 | 0 | 0 | ||
Tricida, Inc. | COM | 89610F101 | 77,732 | 1,969,905 | SH | SOLE | 1,969,905 | 0 | 0 | ||
Trillium Therapeutics Inc. | COM | 89620X506 | 166 | 505,262 | SH | SOLE | 505,262 | 0 | 0 | ||
uniQure N.V. | SHS | N90064101 | 40,458 | 517,700 | SH | SOLE | 517,700 | 0 | 0 | ||
Viking Therapeutics, Inc. | COM | 92686J106 | 3,528 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
XBiotech Inc. | COM | 98400H102 | 2,884 | 380,442 | SH | SOLE | 380,442 | 0 | 0 | ||
Xencor, Inc. | COM | 98401F105 | 17,523 | 428,120 | SH | SOLE | 428,120 | 0 | 0 | ||
Y-mAbs Therapeutics, Inc. | COM | 984241109 | 2,351 | 102,800 | SH | SOLE | 102,800 | 0 | 0 | ||
Zymeworks Inc. | COM | 98985W102 | 37,586 | 1,708,472 | SH | SOLE | 1,708,472 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | NOTE 0.599% 8/1/2024 | 09061GAH4 | 15,566 | 15,000,000 | PRN | SOLE | 15,000,000 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | NOTE 2.25% 5/15/2024 | 64125CAD1 | 40,541 | 30,770,000 | PRN | SOLE | 30,770,000 | 0 | 0 |